
From Doncaster Pharmaceuticals
From Doncaster Pharmaceuticals Group Limited, to Doncaster Pharma Limited, BModesto Group, are relaunching and rebranding Doncaster Pharmaceuticals Group Limited (DPGL) after a recent partial buyout.
From Doncaster Pharmaceuticals Group Limited, to Doncaster Pharma Limited, BModesto Group, are relaunching and rebranding Doncaster Pharmaceuticals Group Limited (DPGL) after a recent partial buyout.
Fake online pharmacies equal fake meds, and there are still online pharmacies who are operating illegally and suppling fake/counterfeit medications to the public for a fee.
Orphan medicines are medicinal products that are intended to treat diseases which are so uncommon that it would be difficult to secure funding for drug development under usual marketing conditions.
Conditional Marketing Authorisations (CMAs) were introduced in Great Britain as a scheme by the MHRA in January 2021. The CMAs can be granted for new medicinal products in GB whose benefits outweigh the potential risks of the new medicinal product.
Do you supply to customers in Northern Ireland – If you do, then you will be aware of a range of issues following Brexit and that we are still some way away from a long term agreement. However, we wanted to highlight a specific issue.